The following is reprinted from the November 4 issue of the UI Holden Comprehensive Cancer Center’s Holden Highlights newsletter. See other features from this series. Christopher Strouse, MD, clinical assistant professor and leader of the Myeloma Multidisciplinary Oncology Group at the University of Iowa, is working tirelessly to increase access to cutting-edge clinical trials for […]
C. Strouse wins $25k Dorfman award
In a celebration of excellence, one of University of Iowa Health Care’s (UIHC) own hematologist-oncologist embodies the ideals of patient care and groundbreaking research by leading his team to secure a prestigious award. Clinical Assistant Professor of Internal Medicine Christopher Strouse, MD, received the 2023 Donald D. Dorfman Award for lymphoma research in the amount […]
Strouse named Myeloma MOG leader
Christopher Strouse, MD, clinical assistant professor and hematologist within the Division of Hematology, Oncology, and Blood & Marrow Transplantation, now leads the multidisciplinary oncology group (MOG) for myeloma at UI’s Holden Comprehensive Cancer Center (HCCC). MOGs, as detailed here, are defined teams within the HCCC, each one organized around a specific type of cancer. There […]
Hem/Onc fellow, faculty granted access to international database for retrospective study
Two Iowa researchers—third-year hematology and oncology fellow Kittika Poonsombudlert, MD, and Christopher Strouse, MD, clinical assistant professor in Hematology, Oncology, and Blood & Marrow Transplantation—will examine potential cardiovascular risks from a drug in a recently approved study. The proposal, “Post-Transplant Cyclophosphamide Related Cardiomyopathy; incidence, risk factors, and outcome,” was approved by the Center for International […]